European Committee Takes a Second Look at Alzheimer's Drug and Now Says It Should Be Approved

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug

aldoguerra851@gmail.com aldoguerra851@gmail.com
Nov 14, 2024 - 14:56
27 0
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug
Read More